Bioengineered protein-based nanocage for drug delivery.

Nature, in its wonders, presents and assembles the most intricate and delicate protein structures and this remarkable phenomenon occurs in all kingdom and phyla of life. Of these proteins, cage-like multimeric proteins provide spatial control to biological processes and also compartmentalizes compounds that may be toxic or unstable and avoids their contact with the environment. Protein-based nanocages are of particular interest because of their potential applicability as drug delivery carriers and their perfect and complex symmetry and ideal physical properties, which have stimulated researchers to engineer, modify or mimic these qualities. This article reviews various existing types of protein-based nanocages that are used for therapeutic purposes, and outlines their drug-loading mechanisms and bioengineering strategies via genetic and chemical functionalization. Through a critical evaluation of recent advances in protein nanocage-based drug delivery in vitro and in vivo, an outlook for de novo and in silico nanocage design, and also protein-based nanocage preclinical and future clinical applications will be presented.

[1]  John E. Johnson,et al.  The role of subunit hinges and molecular "switches" in the control of viral capsid polymorphism. , 2006, Journal of structural biology.

[2]  J. Champion,et al.  Protein nanoparticles for therapeutic protein delivery. , 2015, Biomaterials science.

[3]  So Jin Lee,et al.  Engineered Proteinticles for Targeted Delivery of siRNA to Cancer Cells , 2015 .

[4]  J. Hess,et al.  Efficient Intracellular Delivery of a Protein and a Low Molecular Weight Substance via Recombinant Polyomavirus-like Particles* , 2004, Journal of Biological Chemistry.

[5]  M. Finn,et al.  Cell Targeting with Hybrid Qβ Virus‐Like Particles Displaying Epidermal Growth Factor , 2011, Chembiochem : a European journal of chemical biology.

[6]  Chin-Tarng Lin,et al.  Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery , 2008, Molecular Cancer Therapeutics.

[7]  Hongwei Shang,et al.  A Novel Vaccine Using Nanoparticle Platform to Present Immunogenic M2e against Avian Influenza Infection , 2011, Influenza research and treatment.

[8]  M. Hashizume,et al.  Biological evaluation of protein nanocapsules containing doxorubicin , 2013, International journal of nanomedicine.

[9]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[10]  J. E. Mealy,et al.  Interior engineering of a viral nanoparticle and its tumor homing properties. , 2012, Biomacromolecules.

[11]  David J Brayden,et al.  Controlled release technologies for drug delivery. , 2003, Drug discovery today.

[12]  Jun Wang,et al.  Protein-based nanomedicine platforms for drug delivery. , 2009, Small.

[13]  Duane E. Prasuhn,et al.  Plasma clearance of bacteriophage Qbeta particles as a function of surface charge. , 2008, Journal of the American Chemical Society.

[14]  Allie C. Obermeyer,et al.  Oxidative modification of native protein residues using cerium(IV) ammonium nitrate. , 2011, Journal of the American Chemical Society.

[15]  K. Schwarz,et al.  Nonmethylated CG Motifs Packaged into Virus-Like Particles Induce Protective Cytotoxic T Cell Responses in the Absence of Systemic Side Effects , 2004, The Journal of Immunology.

[16]  W. Brown,et al.  Delivery of antisense oligonucleotides to leukemia cells by RNA bacteriophage capsids. , 2005, Nanomedicine : nanotechnology, biology, and medicine.

[17]  Mark B. Carter,et al.  Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles. , 2011, ACS nano.

[18]  Jean-Pierre Andrieu,et al.  Adenovirus Dodecahedron, as a Drug Delivery Vector , 2009, PloS one.

[19]  J. Whittle,et al.  Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies , 2013, Nature.

[20]  P. Prevelige,et al.  Virus-like particle nanoreactors: programmed encapsulation of the thermostable CelB glycosidase inside the P22 capsid , 2012 .

[21]  N. Steinmetz,et al.  Infusion of imaging and therapeutic molecules into the plant virus-based carrier cowpea mosaic virus: cargo-loading and delivery. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[22]  D. Baker,et al.  Computational Design of Self-Assembling Protein Nanomaterials with Atomic Level Accuracy , 2012, Science.

[23]  N. Elad,et al.  Improved Doxorubicin Encapsulation and Pharmacokinetics of Ferritin-Fusion Protein Nanocarriers Bearing Proline, Serine, and Alanine Elements. , 2016, Biomacromolecules.

[24]  Greg L. Hura,et al.  Structure of a Designed Protein Cage that Self-Assembles into a Highly Porous Cube , 2014, Nature chemistry.

[25]  R. Nolte,et al.  Natural supramolecular protein assemblies. , 2016, Chemical Society reviews.

[26]  Yu-Ying He,et al.  Pristine (C60) and hydroxylated [C60(OH)24] fullerene phototoxicity towards HaCaT keratinocytes: type I vs type II mechanisms. , 2008, Chemical Research in Toxicology.

[27]  Sang J. Chung,et al.  Developing an antibody-binding protein cage as a molecular recognition drug modular nanoplatform. , 2012, Biomaterials.

[28]  Youyu Zhang,et al.  Apoferritin-based nanomedicine platform for drug delivery: equilibrium binding study of daunomycin with DNA , 2011 .

[29]  M. McConnell,et al.  Protein cage nanoparticles bearing the LyP-1 peptide for enhanced imaging of macrophage-rich vascular lesions. , 2011, ACS nano.

[30]  Derek N. Woolfson,et al.  More than just bare scaffolds: towards multi-component and decorated fibrous biomaterials. , 2010, Chemical Society reviews.

[31]  Andrew K. Udit,et al.  Defining criteria for oligomannose immunogens for HIV using icosahedral virus capsid scaffolds. , 2010, Chemistry & biology.

[32]  M. Hashizume,et al.  Design and Function of Engineered Protein Nanocages as a Drug Delivery System for Targeting Pancreatic Cancer Cells via Neuropilin-1. , 2015, Molecular pharmaceutics.

[33]  J. Szostak,et al.  In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.

[34]  Kwangmeyung Kim,et al.  Systemic delivery of siRNA by chimeric capsid protein: tumor targeting and RNAi activity in vivo. , 2013, Molecular pharmaceutics.

[35]  M. Young,et al.  A click chemistry based coordination polymer inside small heat shock protein. , 2010, Chemical communications.

[36]  M. Francis,et al.  Oxidative coupling of peptides to a virus capsid containing unnatural amino acids. , 2008, Chemical communications.

[37]  Trevor Douglas,et al.  Host–guest encapsulation of materials by assembled virus protein cages , 1998, Nature.

[38]  Kedar G. Patel,et al.  Surface functionalization of virus-like particles by direct conjugation using azide-alkyne click chemistry. , 2011, Bioconjugate chemistry.

[39]  J. Bale,et al.  Structure of a designed tetrahedral protein assembly variant engineered to have improved soluble expression , 2015, Protein science : a publication of the Protein Society.

[40]  N. Stephanopoulos,et al.  Dual-surface modified virus capsids for targeted delivery of photodynamic agents to cancer cells. , 2010, ACS nano.

[41]  S. Müller,et al.  Optimizing the refolding conditions of self-assembling polypeptide nanoparticles that serve as repetitive antigen display systems , 2011, Journal of Structural Biology.

[42]  V. Kickhoefer,et al.  Targeted vault nanoparticles engineered with an endosomolytic peptide deliver biomolecules to the cytoplasm. , 2011, ACS nano.

[43]  Upendra K. Kar,et al.  Vault Nanocapsules as Adjuvants Favor Cell-Mediated over Antibody-Mediated Immune Responses following Immunization of Mice , 2012, PloS one.

[44]  U. Sleytr,et al.  A Novel Approach to Specific Allergy Treatment: The Recombinant Allergen-S-Layer Fusion Protein rSbsC-Bet v 1 Matures Dendritic Cells That Prime Th0/Th1 and IL-10-Producing Regulatory T Cells1 , 2007, The Journal of Immunology.

[45]  P. Prevelige,et al.  Implementation of p22 viral capsids as nanoplatforms. , 2010, Biomacromolecules.

[46]  V. Kickhoefer,et al.  Cryoelectron microscopy imaging of recombinant and tissue derived vaults: localization of the MVP N termini and VPARP. , 2004, Journal of molecular biology.

[47]  Yuehe Lin,et al.  Hyaluronic acid-conjugated apoferritin nanocages for lung cancer targeted drug delivery. , 2015, Biomaterials science.

[48]  T. Daniels,et al.  The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer. , 2006, Clinical immunology.

[49]  Hongzhe Sun,et al.  Encapsulation of platinum anticancer drugs by apoferritin. , 2007, Chemical communications.

[50]  John E. Johnson,et al.  Heterologous expression of the modified coat protein of Cowpea chlorotic mottle bromovirus results in the assembly of protein cages with altered architectures and function. , 2004, The Journal of general virology.

[51]  V. Kickhoefer,et al.  Targeting vault nanoparticles to specific cell surface receptors. , 2009, ACS nano.

[52]  Inge J. Minten,et al.  Virus-like particles templated by DNA micelles: a general method for loading virus nanocarriers. , 2010, Journal of the American Chemical Society.

[53]  John E. Johnson,et al.  Hybrid virus-polymer materials. 1. Synthesis and properties of PEG-decorated cowpea mosaic virus. , 2003 .

[54]  E. Nelson,et al.  Biomimetic protein nanoparticles facilitate enhanced dendritic cell activation and cross-presentation. , 2013, ACS nano.

[55]  Derek N. Woolfson,et al.  More than Just Bare Scaffolds: Towards Multi-Component and Decorated Fibrous Biomaterials , 2010 .

[56]  Y. Do,et al.  Lumazine synthase protein cage nanoparticles as antigen delivery nanoplatforms for dendritic cell-based vaccine development , 2014, Clinical and experimental vaccine research.

[57]  Zhijun Zhang,et al.  Self-assembled virus-like particles from rotavirus structural protein VP6 for targeted drug delivery. , 2011, Bioconjugate chemistry.

[58]  B. Cargile,et al.  Identification of bacteriophage MS2 coat protein from E. coli lysates via ion trap collisional activation of intact protein ions. , 2001, Analytical chemistry.

[59]  John E. Johnson,et al.  Natural supramolecular building blocks. Wild-type cowpea mosaic virus. , 2002, Chemistry & biology.

[60]  Mihee M. Kim,et al.  pH-dependent structures of ferritin and apoferritin in solution: disassembly and reassembly. , 2011, Biomacromolecules.

[61]  M. Young,et al.  Targeting and photodynamic killing of a microbial pathogen using protein cage architectures functionalized with a photosensitizer. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[62]  T. Douglas,et al.  Iron and cobalt oxide and metallic nanoparticles prepared from ferritin. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[63]  P. Pumpens,et al.  Mosaic Qβ coats as a new presentation model , 1998 .

[64]  In‐San Kim,et al.  Chimeric capsid protein as a nanocarrier for siRNA delivery: stability and cellular uptake of encapsulated siRNA. , 2011, ACS nano.

[65]  S. Schmid,et al.  Multivalent Display and Receptor‐Mediated Endocytosis of Transferrin on Virus‐Like Particles , 2010, Chembiochem : a European journal of chemical biology.

[66]  Shuguang Zhang Fabrication of novel biomaterials through molecular self-assembly , 2003, Nature Biotechnology.

[67]  Jiansheng Liang,et al.  Cucumber mosaic virus as drug delivery vehicle for doxorubicin. , 2013, Biomaterials.

[68]  M. Hashizume,et al.  Development of human hepatocellular carcinoma cell-targeted protein cages. , 2012, Bioconjugate chemistry.

[69]  Fan Zhang,et al.  Chimeric ferritin nanocages for multiple function loading and multimodal imaging. , 2011, Nano letters.

[70]  Stephan Wilkens,et al.  Deletion of Highly Conserved Arginine-Rich RNA Binding Motif in Cowpea Chlorotic Mottle Virus Capsid Protein Results in Virion Structural Alterations and RNA Packaging Constraints , 2005, Journal of Virology.

[71]  Qin Guo,et al.  Protective Antibody and CD8+ T-Cell Responses to the Plasmodium falciparum Circumsporozoite Protein Induced by a Nanoparticle Vaccine , 2012, PloS one.

[72]  Jacob M Hooker,et al.  Interior surface modification of bacteriophage MS2. , 2004, Journal of the American Chemical Society.

[73]  M. Santoro,et al.  Heat shock factors and the control of the stress response. , 2000, Biochemical pharmacology.

[74]  E. Chiancone,et al.  Thermal stability of horse spleen apoferritin and human recombinant H apoferritin. , 1996, Archives of biochemistry and biophysics.

[75]  V. Kickhoefer,et al.  Bioengineered Vaults: Self-Assembling Protein Shell–Lipophilic Core Nanoparticles for Drug Delivery , 2014, ACS nano.

[76]  O. Benada,et al.  Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles , 2012, International journal of nanomedicine.

[77]  V. Kickhoefer,et al.  Vaults engineered for hydrophobic drug delivery. , 2011, Small.

[78]  S. Raman,et al.  Nanoscale assemblies and their biomedical applications , 2013, Journal of The Royal Society Interface.

[79]  Wei Wang,et al.  Development of an antisense RNA delivery system using conjugates of the MS2 bacteriophage capsids and HIV-1 TAT cell-penetrating peptide. , 2009, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[80]  P. Prevelige,et al.  Use of the interior cavity of the P22 capsid for site-specific initiation of atom-transfer radical polymerization with high-density cargo loading. , 2012, Nature chemistry.

[81]  M. Finn,et al.  Virus-glycopolymer conjugates by copper(I) catalysis of atom transfer radical polymerization and azide-alkyne cycloaddition. , 2005, Chemical communications.

[82]  D. Ho,et al.  CD40L-Containing Virus-Like Particle as a Candidate HIV-1 Vaccine Targeting Dendritic Cells , 2011, Journal of acquired immune deficiency syndromes.

[83]  B. Wiedenheft,et al.  Programmed Self-Assembly of an Active P22-Cas9 Nanocarrier System. , 2016, Molecular pharmaceutics.

[84]  K. Nagayama,et al.  Permeation of small molecules into the cavity of ferritin as revealed by proton nuclear magnetic resonance relaxation. , 1995, The Biochemical journal.

[85]  Trevor Douglas,et al.  Viruses: Making Friends with Old Foes , 2006, Science.

[86]  Donald Hilvert,et al.  Directed Evolution of a Protein Container , 2011, Science.

[87]  N. Steinmetz,et al.  Development of viral nanoparticles for efficient intracellular delivery. , 2012, Nanoscale.

[88]  Q. Wang,et al.  Icosahedral Virus Particles as Polyvalent Carbohydrate Display Platforms , 2003, Chembiochem : a European journal of chemical biology.

[89]  P. Prevelige,et al.  Genetically programmed in vivo packaging of protein cargo and its controlled release from bacteriophage P22. , 2011, Angewandte Chemie.

[90]  Qian Wang,et al.  Adaptations of nanoscale viruses and other protein cages for medical applications. , 2006, Nanomedicine : nanotechnology, biology, and medicine.

[91]  S. Kim,et al.  Lumazine synthase protein cage nanoparticles as modular delivery platforms for targeted drug delivery , 2014 .

[92]  M. Morris,et al.  Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics , 2009, British journal of pharmacology.

[93]  H. Pasolli,et al.  Virus-Like Particles Harboring CCL19, IL-2 and HPV16 E7 Elicit Protective T Cell Responses in HLA-A2 Transgenic Mice , 2012, The open virology journal.

[94]  S. Howorka Rationally engineering natural protein assemblies in nanobiotechnology. , 2011, Current opinion in biotechnology.

[95]  David Baker,et al.  Accurate design of co-assembling multi-component protein nanomaterials , 2014, Nature.

[96]  D. Clark,et al.  Solubilization and stabilization of bacteriophage MS2 in organic solvents , 2007, Biotechnology and bioengineering.

[97]  John E. Johnson,et al.  Potato virus X as a novel platform for potential biomedical applications. , 2010, Nano letters.

[98]  Gustavo Helguera,et al.  The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells. , 2006, Clinical immunology.

[99]  G. Lomonossoff,et al.  Cowpea mosaic virus-based chimaeras. Effects of inserted peptides on the phenotype, host range, and transmissibility of the modified viruses. , 2003, Virology.

[100]  Dongmei Ren,et al.  Protein nanocapsules containing doxorubicin as a pH-responsive delivery system. , 2011, Small.

[101]  In‐San Kim,et al.  A Double‐Chambered Protein Nanocage Loaded with Thrombin Receptor Agonist Peptide (TRAP) and γ‐Carboxyglutamic Acid of Protein C (PC‐Gla) for Sepsis Treatment , 2015, Advanced materials.

[102]  R. Naik,et al.  Engineered protein cages for nanomaterial synthesis. , 2004, Journal of the American Chemical Society.

[103]  Rui Zhang,et al.  MS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupus-prone mice , 2012, International journal of nanomedicine.

[104]  John A. Robinson,et al.  Synthetic virus-like particles from self-assembling coiled-coil lipopeptides and their use in antigen display to the immune system. , 2007, Angewandte Chemie.

[105]  N. Steinmetz,et al.  Cowpea mosaic virus for material fabrication: addressable carboxylate groups on a programmable nanoscaffold. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[106]  S. Raman,et al.  Structure-based design of peptides that self-assemble into regular polyhedral nanoparticles. , 2006, Nanomedicine : nanotechnology, biology, and medicine.

[107]  Trevor Douglas,et al.  A streptavidin-protein cage Janus particle for polarized targeting and modular functionalization. , 2009, Journal of the American Chemical Society.

[108]  Miss A.O. Penney (b) , 1974, The New Yale Book of Quotations.

[109]  V. Kickhoefer,et al.  A Vault Nanoparticle Vaccine Induces Protective Mucosal Immunity , 2009, PloS one.

[110]  M. Hashizume,et al.  A nanocarrier based on a genetically engineered protein cage to deliver doxorubicin to human hepatocellular carcinoma cells. , 2013, Chemical communications.

[111]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[112]  Corwin M. Nycholat,et al.  Colorful virus-like particles: fluorescent protein packaging by the Qβ capsid. , 2011, Biomacromolecules.

[113]  Rajesh R Naik,et al.  Protein- and peptide-directed syntheses of inorganic materials. , 2008, Chemical reviews.

[114]  M. Young,et al.  Chemical modification of a viral cage for multivalent presentation. , 2002, Chemical communications.

[115]  J. Chang,et al.  In vitro and in vivo targeted delivery of IL-10 interfering RNA by JC virus-like particles , 2010, Journal of Biomedical Science.

[116]  Arlo Z. Randall,et al.  Biomimetic Design of Protein Nanomaterials for Hydrophobic Molecular Transport , 2012, Advanced functional materials.

[117]  Duane E. Prasuhn,et al.  Unnatural amino acid incorporation into virus-like particles. , 2008, Bioconjugate chemistry.

[118]  B. Schwarz,et al.  Development of virus-like particles for diagnostic and prophylactic biomedical applications. , 2015, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[119]  Sonny C. Hsiao,et al.  Viral capsid DNA aptamer conjugates as multivalent cell-targeting vehicles. , 2009, Journal of the American Chemical Society.

[120]  M. Finn,et al.  Accelerated bioorthogonal conjugation: a practical method for the ligation of diverse functional molecules to a polyvalent virus scaffold. , 2005, Bioconjugate chemistry.

[121]  Yuguang Du,et al.  Bio-inspired protein-gold nanoconstruct with core-void-shell structure: beyond a chemo drug carrier. , 2013, Journal of materials chemistry. B.

[122]  P. Pumpens,et al.  RNA Phage Qβ Coat Protein as a Carrier for Foreign Epitopes , 1996 .

[123]  Satish K. Nune,et al.  Nanoparticles for biomedical imaging , 2009, Expert opinion on drug delivery.

[124]  S. Achilefu,et al.  A paclitaxel-conjugated adenovirus vector for targeted drug delivery for tumor therapy. , 2012, Biomaterials.

[125]  M. Young,et al.  Selective attachment and release of a chemotherapeutic agent from the interior of a protein cage architecture. , 2005, Chemical communications.

[126]  P. Prevelige,et al.  Coconfinement of fluorescent proteins: spatially enforced communication of GFP and mCherry encapsulated within the P22 capsid. , 2012, Biomacromolecules.

[127]  V. Marchesi,et al.  Chemical characterization and surface orientation of the major glycoprotein of the human erythrocyte membrane. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[128]  Inge J. Minten,et al.  Controlled encapsulation of multiple proteins in virus capsids. , 2009, Journal of the American Chemical Society.

[129]  Lars Liljas,et al.  The three-dimensional structure of the bacterial virus MS2 , 1990, Nature.

[130]  P. Prevelige,et al.  P22 viral capsids as nanocomposite high-relaxivity MRI contrast agents. , 2013, Molecular pharmaceutics.

[131]  Philip S Low,et al.  Folate-mediated delivery of macromolecular anticancer therapeutic agents. , 2002, Advanced drug delivery reviews.

[132]  Tian Xia,et al.  Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. , 2011, ACS nano.

[133]  Horst Kessler,et al.  Guiding plant virus particles to integrin-displaying cells. , 2012, Nanoscale.

[134]  T. Gedeon,et al.  Encapsulation of an enzyme cascade within the bacteriophage P22 virus-like particle. , 2014, ACS chemical biology.

[135]  N. Steinmetz,et al.  PEGylated viral nanoparticles for biomedicine: the impact of PEG chain length on VNP cell interactions in vitro and ex vivo. , 2009, Biomacromolecules.

[136]  M. Bellini,et al.  Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in Cancer Cells. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[137]  A. Rynda-Apple,et al.  Biomimetic antigenic nanoparticles elicit controlled protective immune response to influenza. , 2013, ACS nano.

[138]  P. Couvreur,et al.  A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles , 2005, Cellular and Molecular Life Sciences.

[139]  P. Burkhard,et al.  Conformation‐specific Display of 4E10 and 2F5 Epitopes on Self‐assembling Protein Nanoparticles as a Potential HIV Vaccine , 2012, Chemical biology & drug design.

[140]  A. Bleloch,et al.  3D morphology of the human hepatic ferritin mineral core: New evidence for a subunit structure revealed by single particle analysis of HAADF-STEM images , 2009, Journal of structural biology.

[141]  Serdar Kuyucak,et al.  Functional properties of threefold and fourfold channels in ferritin deduced from electrostatic calculations. , 2003, Biophysical journal.

[142]  H. Maeda,et al.  Carbon monoxide, generated by heme oxygenase‐1, mediates the enhanced permeability and retention effect in solid tumors , 2012, Cancer science.

[143]  V. Kickhoefer,et al.  Assembly of Vault-like Particles in Insect Cells Expressing Only the Major Vault Protein* , 2001, The Journal of Biological Chemistry.

[144]  John E. Johnson,et al.  Hybrid virus-polymer materials. 1. Synthesis and properties of PEG-decorated cowpea mosaic virus. , 2003, Biomacromolecules.

[145]  M. Young,et al.  Targeted Delivery of a Photosensitizer to Aggregatibacter actinomycetemcomitans Biofilm , 2010, Antimicrobial Agents and Chemotherapy.

[146]  John E. Johnson,et al.  Generation and structural analysis of reactive empty particles derived from an icosahedral virus. , 2006, Chemistry & biology.

[147]  Warren C W Chan,et al.  The effect of nanoparticle size, shape, and surface chemistry on biological systems. , 2012, Annual review of biomedical engineering.

[148]  P. Burkhard,et al.  Coiled coils: a highly versatile protein folding motif. , 2001, Trends in cell biology.

[149]  B. Gallois,et al.  Crystal structure and biochemical properties of the human mitochondrial ferritin and its mutant Ser144Ala. , 2004, Journal of molecular biology.

[150]  V. Kickhoefer,et al.  Structural stability of vault particles. , 2009, Journal of pharmaceutical sciences.

[151]  M. Young,et al.  Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles. , 2006, Journal of the American Chemical Society.

[152]  S. Zhang,et al.  Incorporation of CD40 ligand into SHIV virus-like particles (VLP) enhances SHIV-VLP-induced dendritic cell activation and boosts immune responses against HIV. , 2010, Vaccine.

[153]  W. Berger,et al.  Vaults and the major vault protein: Novel roles in signal pathway regulation and immunity , 2008, Cellular and Molecular Life Sciences.

[154]  L. Liljas,et al.  Crystallization and preliminary X-ray diffraction studies of the bacteriophage Qbeta. , 1994, Acta crystallographica. Section D, Biological crystallography.

[155]  M. Young,et al.  Supramolecular protein cage composite MR contrast agents with extremely efficient relaxivity properties. , 2009, Nano letters.

[156]  J. Paulson,et al.  On-virus construction of polyvalent glycan ligands for cell-surface receptors. , 2008, Journal of the American Chemical Society.

[157]  Vault nanocapsule dissociation into halves triggered at low pH. , 2007, Biochemistry.

[158]  Stephen H. Hughes,et al.  Protein delivery using engineered virus-like particles , 2011, Proceedings of the National Academy of Sciences.

[159]  M. Hashizume,et al.  Liver cell specific targeting by the preS1 domain of hepatitis B virus surface antigen displayed on protein nanocages , 2012, International journal of nanomedicine.

[160]  Jan C M van Hest,et al.  Functionalization of protein-based nanocages for drug delivery applications. , 2014, Nanoscale.

[161]  Corwin M. Nycholat,et al.  Glycan-targeted virus-like nanoparticles for photodynamic therapy. , 2012, Biomacromolecules.

[162]  Hyun-Jae Shin,et al.  Viruses as self-assembled nanocontainers for encapsulation of functional cargoes , 2013, Korean Journal of Chemical Engineering.

[163]  R. Hodges,et al.  Peptide Nanoparticles as Novel Immunogens: Design and Analysis of a Prototypic Severe Acute Respiratory Syndrome Vaccine , 2008, Chemical biology & drug design.

[164]  Allie C. Obermeyer,et al.  Rapid chemoselective bioconjugation through oxidative coupling of anilines and aminophenols. , 2011, Journal of the American Chemical Society.

[165]  D. Hilvert,et al.  A simple tagging system for protein encapsulation. , 2006, Journal of the American Chemical Society.

[166]  Y. Sun,et al.  Small heat shock proteins: molecular structure and chaperone function , 2005, Cellular and Molecular Life Sciences CMLS.

[167]  N. Steinmetz,et al.  Buckyballs meet viral nanoparticles: candidates for biomedicine. , 2009, Journal of the American Chemical Society.

[168]  R. Gref,et al.  Synthetic and bioinspired cage nanoparticles for drug delivery. , 2014, Nanomedicine.

[169]  R. Dummer,et al.  Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8+ T-cell responses in melanoma patients , 2012, European journal of immunology.

[170]  K. Breitenkamp,et al.  Functional virus-based polymer-protein nanoparticles by atom transfer radical polymerization. , 2011, Journal of the American Chemical Society.

[171]  V. Kickhoefer,et al.  Vault nanoparticles containing an adenovirus-derived membrane lytic protein facilitate toxin and gene transfer. , 2009, ACS nano.

[172]  D. A. Kharkevich,et al.  Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study. , 1998, Journal of microencapsulation.

[173]  Jin Xie,et al.  RGD-modified apoferritin nanoparticles for efficient drug delivery to tumors. , 2013, ACS nano.

[174]  M. Bova,et al.  Subunit Exchange, Conformational Stability, and Chaperone-like Function of the Small Heat Shock Protein 16.5 fromMethanococcus jannaschii * , 2002, The Journal of Biological Chemistry.

[175]  A. Vahrmeijer,et al.  Targeting integrins and enhanced permeability and retention (EPR) effect for optical imaging of oral cancer , 2012, Journal of surgical oncology.

[176]  John E. Johnson,et al.  Natural supramolecular building blocks. Cysteine-added mutants of cowpea mosaic virus. , 2002, Chemistry & biology.

[177]  Trevor Douglas,et al.  The Small Heat Shock Protein Cage from Methanococcus jannaschii Is a Versatile Nanoscale Platform for Genetic and Chemical Modification , 2003 .

[178]  A. Rynda-Apple,et al.  A virus-like particle vaccine platform elicits heightened and hastened local lung mucosal antibody production after a single dose , 2012, Vaccine.

[179]  J. Fiedler,et al.  Assembly of hybrid bacteriophage Qbeta virus-like particles. , 2009, Biochemistry.

[180]  Derek N. Woolfson,et al.  Engineering nanoscale order into a designed protein fiber , 2007, Proceedings of the National Academy of Sciences.

[181]  Kwangmeyung Kim,et al.  Proteinticle/Gold Core/Shell Nanoparticles for Targeted Cancer Therapy without Nanotoxicity , 2014, Advanced materials.

[182]  D. Woolfson,et al.  Peptide and protein based materials in 2010: from design and structure to function and application. , 2010, Chemical Society reviews.

[183]  N. Steinmetz,et al.  Hydrazone ligation strategy to assemble multifunctional viral nanoparticles for cell imaging and tumor targeting. , 2010, Nano letters.

[184]  Sung-Hou Kim,et al.  Crystal structure of a small heat-shock protein , 1998, Nature.

[185]  M. Finn,et al.  Blue fluorescent antibodies as reporters of steric accessibility in virus conjugates. , 2003, Bioconjugate chemistry.

[186]  G. Whitesides The 'right' size in nanobiotechnology , 2003, Nature Biotechnology.

[187]  A. Lascialfari,et al.  MRI relaxation properties of water-soluble apoferritin-encapsulated gadolinium oxide-hydroxide nanoparticles. , 2009, Dalton transactions.

[188]  Sebyung Kang,et al.  Developing genetically engineered encapsulin protein cage nanoparticles as a targeted delivery nanoplatform. , 2014, Biomacromolecules.

[189]  Marianne Manchester,et al.  Folic acid-mediated targeting of cowpea mosaic virus particles to tumor cells. , 2007, Chemistry & biology.

[190]  N. Steinmetz,et al.  Increased tumor homing and tissue penetration of the filamentous plant viral nanoparticle Potato virus X. , 2013, Molecular pharmaceutics.

[191]  M. Manchester,et al.  Biomedical nanotechnology using virus-based nanoparticles. , 2009, Current topics in microbiology and immunology.

[192]  Hoai Viet Nguyen,et al.  Apoferritin Modified Magnetic Particles as Doxorubicin Carriers for Anticancer Drug Delivery , 2013, International journal of molecular sciences.

[193]  U. Aebi,et al.  The biodistribution of self-assembling protein nanoparticles shows they are promising vaccine platforms , 2013, Journal of Nanobiotechnology.

[194]  Zhi-ping Zhang,et al.  Multifunctional ferritin cage nanostructures for fluorescence and MR imaging of tumor cells. , 2012, Nanoscale.

[195]  Y. Tong,et al.  Self-assembly of collagen-mimetic peptide amphiphiles into biofunctional nanofiber. , 2011, ACS nano.

[196]  Sung You Hong,et al.  Ferritin protein cage nanoparticles as versatile antigen delivery nanoplatforms for dendritic cell (DC)-based vaccine development. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[197]  Zakir Hossain,et al.  Prospects and applications of nanobiotechnology: a medical perspective , 2012, Journal of Nanobiotechnology.

[198]  M. Young,et al.  Controlled ligand display on a symmetrical protein-cage architecture through mixed assembly. , 2006, Small.

[199]  In‐San Kim,et al.  Designed nanocage displaying ligand-specific Peptide bunches for high affinity and biological activity. , 2013, ACS nano.

[200]  Dongling Yang,et al.  H-ferritin–nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection , 2014, Proceedings of the National Academy of Sciences.

[201]  Duilio Cascio,et al.  Structure of a 16-nm Cage Designed by Using Protein Oligomers , 2012, Science.

[202]  Sek-Man Wong,et al.  Folic acid-conjugated protein cages of a plant virus: a novel delivery platform for doxorubicin. , 2007, Bioconjugate chemistry.

[203]  M. Kinjo,et al.  Virus-like particles with removable cyclodextrins enable glutathione-triggered drug release in cells. , 2013, Molecular bioSystems.

[204]  A. Heck,et al.  Encapsulation of phthalocyanine supramolecular stacks into virus-like particles. , 2011, Journal of the American Chemical Society.

[205]  Jennifer E. Padilla,et al.  Nanohedra: Using symmetry to design self assembling protein cages, layers, crystals, and filaments , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[206]  J. Hainfeld,et al.  Uranium-loaded apoferritin with antibodies attached: molecular design for uranium neutron-capture therapy. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[207]  A. Rynda-Apple,et al.  Immunopathology and Infectious Diseases Virus-Like Particle-Induced Protection Against MRSA Pneumonia Is Dependent on IL-13 and Enhancement of Phagocyte Function , 2012 .

[208]  Nicole F Steinmetz,et al.  The art of engineering viral nanoparticles. , 2011, Molecular pharmaceutics.

[209]  H. Horinouchi,et al.  Structure, photophysical property, and cytotoxicity of human serum albumin complexed with tris(dicarboxymethylene)[60]fullerene. , 2008, Bioconjugate chemistry.

[210]  Marianne Manchester,et al.  Viruses and their uses in nanotechnology , 2006 .

[211]  M G Finn,et al.  RNA-directed packaging of enzymes within virus-like particles. , 2010, Angewandte Chemie.

[212]  Nicole F Steinmetz,et al.  Intravital imaging of human prostate cancer using viral nanoparticles targeted to gastrin-releasing Peptide receptors. , 2011, Small.

[213]  V. Kickhoefer,et al.  Development of the vault particle as a platform technology. , 2013, ACS nano.

[214]  N. Normanno,et al.  Epidermal growth factor receptor (EGFR) signaling in cancer. , 2006, Gene.

[215]  Yuan Zhang,et al.  Development of a microRNA delivery system based on bacteriophage MS2 virus‐like particles , 2012, The FEBS journal.

[216]  P. Stockley,et al.  MS2 viruslike particles: a robust, semisynthetic targeted drug delivery platform. , 2013, Molecular pharmaceutics.

[217]  Min Huang,et al.  Novel CCL21-Vault Nanocapsule Intratumoral Delivery Inhibits Lung Cancer Growth , 2011, PloS one.

[218]  M. Tweedle,et al.  Fine-tuning the pH trigger of self-assembly. , 2012, Journal of the American Chemical Society.

[219]  H. Munro,et al.  Ferritin: structure, biosynthesis, and role in iron metabolism. , 1978, Physiological reviews.

[220]  CARBON MONOXIDECO,et al.  Carbon monoxide. , 2020, JAMA.

[221]  F. Kratz,et al.  Engineered drug-protein nanoparticle complexes for folate receptor targeting. , 2014, Biochemical engineering journal.

[222]  Bing Xu,et al.  Applications of nanomaterials inside cells , 2009 .

[223]  John E. Johnson,et al.  Structures of the native and swollen forms of cowpea chlorotic mottle virus determined by X-ray crystallography and cryo-electron microscopy. , 1995, Structure.

[224]  R. Crichton,et al.  The catalytic activity of horse spleen apoferritin. Preliminary kinetic studies and the effect of chemical modification. , 1973, The Biochemical journal.

[225]  John E. Johnson,et al.  Natural Nanochemical Building Blocks: Icosahedral Virus Particles Organized by Attached Oligonucleotides , 2004 .

[226]  Peter G Stockley,et al.  Engineering thermal stability in RNA phage capsids via disulphide bonds. , 2005, Journal of nanoscience and nanotechnology.

[227]  Jing C. Zhou,et al.  Engineering of vault nanocapsules with enzymatic and fluorescent properties. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[228]  P. Prevelige,et al.  Nanoreactors by programmed enzyme encapsulation inside the capsid of the bacteriophage P22. , 2012, ACS nano.

[229]  Derek N. Woolfson,et al.  Sticky-end assembly of a designed peptide fiber provides insight into protein fibrillogenesis. , 2000 .

[230]  Nicole F Steinmetz,et al.  Engineering of Brome mosaic virus for biomedical applications. , 2012, RSC advances.

[231]  Donald Hilvert,et al.  Efficient in vitro encapsulation of protein cargo by an engineered protein container. , 2012, Journal of the American Chemical Society.

[232]  Sierin Lim,et al.  Thermostability and molecular encapsulation within an engineered caged protein scaffold , 2008, Biotechnology and bioengineering.

[233]  L. Lai,et al.  On the mechanism of chaperone activity of the small heat-shock protein of Methanococcus jannaschii , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[234]  J. Zhao,et al.  Epidermal growth factor-ferritin H-chain protein nanoparticles for tumor active targeting. , 2012, Small.

[235]  Andries Zijlstra,et al.  Viral nanoparticles as tools for intravital vascular imaging , 2006, Nature Medicine.

[236]  Jacob M Hooker,et al.  Dual-surface-modified bacteriophage MS2 as an ideal scaffold for a viral capsid-based drug delivery system. , 2007, Bioconjugate chemistry.

[237]  John E. Johnson,et al.  Icosahedral virus particles as addressable nanoscale building blocks. , 2002, Angewandte Chemie.

[238]  John E. Johnson,et al.  Chemical conjugation of heterologous proteins on the surface of Cowpea mosaic virus. , 2004, Bioconjugate chemistry.

[239]  Molly K. Gregas,et al.  Apoferritin protein cages: a novel drug nanocarrier for photodynamic therapy. , 2008, Chemical communications.

[240]  Silvio Aime,et al.  Compartmentalization of a gadolinium complex in the apoferritin cavity: a route to obtain high relaxivity contrast agents for magnetic resonance imaging. , 2002, Angewandte Chemie.

[241]  Kwangmeyung Kim,et al.  Hybrid ferritin nanoparticles as activatable probes for tumor imaging. , 2011, Angewandte Chemie.

[242]  Nicole F Steinmetz,et al.  Controlled immobilisation of active enzymes on the cowpea mosaic virus capsid. , 2012, Nanoscale.

[243]  N. Molino,et al.  Caged protein nanoparticles for drug delivery. , 2014, Current opinion in biotechnology.

[244]  G J Strous,et al.  Endocytosis of GPI-linked membrane folate receptor-alpha , 1996, The Journal of cell biology.

[245]  Sebyung Kang,et al.  Genetically engineering encapsulin protein cage nanoparticle as a SCC-7 cell targeting optical nanoprobe , 2014, Biomaterials Research.

[246]  Alaa A. A. Aljabali,et al.  CPMV-DOX delivers. , 2013, Molecular pharmaceutics.

[247]  Derek N. Woolfson,et al.  Rational design and application of responsive α-helical peptide hydrogels , 2009, Nature materials.

[248]  S. Franzen,et al.  The Red clover necrotic mosaic virus capsid as a multifunctional cell targeting plant viral nanoparticle. , 2011, Bioconjugate chemistry.